US 7968511
Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
granted A61KA61K31/137A61K38/02
Quick answer
US patent 7968511 (Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/137, A61K38/02, A61P, A61P25/00